Multicenter Study to Evaluate a Systematized Communication Model for

Status Recruiting

Clinical Trial Summary

Both in Mexico and in the world, breast cancer is the most common malignancy in women. It is estimated that in 2020, 28.2% of the new cancer cases reported in our country correspond to breast cancer, which translates to 30,000 new cases. In addition, it is relevant to mention that approximately 12% of Mexican patients are diagnosed with stage IV breast cancer and it is estimated that 20-30% of women with early stage cancer will have a distant recurrence of the disease. Thus, about 40% of patients will find themselves in a metastatic stage at some point in their breast cancer journey. Various studies, including Mexico, report that only half of patients with metastatic breast cancer are aware that their disease is not curable, 31% say they are not sure, and 17% think it is curable. Likewise, 58% considered that they did not have enough knowledge to actively participate in conversations about their therapeutic options, which means that 40% reported difficulty talking about treatments with their doctors. This has shown that there are suboptimal levels of knowledge information on curability, treatment objectives and prognosis of their condition in patients with metastatic breast cancer. This lack of understanding is alarming given that a general understanding of the disease is crucial for informed decision making and adherence to cancer treatment. Due to these alarming results, we seek to recruit women ≥18 years of age who are candidates to start first- or second-line treatment for de novo or recurrent metastatic breast cancer from various hospital centers in the country with public and private coverage, including Hospital Zambrano Hellion TecSalud as coordinating center in Nuevo León. The objective will be to evaluate whether a systematized communication model for patients with metastatic breast cancer allows increasing knowledge about the non-curative nature of treatment, compared to usual care.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05837533
Study type	Interventional
Source	Medicos e Investigadores en la Lucha contra el Cancer de Mama
Contact	Cynthia Villarreal-Garza, MD, DSc
Phone	5288880000
Email	cynthia.villarreal@tecsalud.mx
Status	Recruiting
Phase	N/A
Start date	May 17, 2023
Completion date	June 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05203146` - PIMPmyHospital: a Mobile App to Improve Emergency Care Efficiency and Communication	N/A
Completed	`NCT04105751` - Testing a Novel Manual Communication System for Mechanically Ventilated ICU Patients	N/A
Completed	`NCT04595695` - The Effect of Clear Masks in Improving Patient Relationships	N/A
Completed	`NCT05540444` - RadConnect Communication Application
Recruiting	`NCT04317664` - Intervention to Improve Driving Practices Among High-Risk Teen Drivers	Phase 3
Completed	`NCT05812599` - Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers	N/A
Completed	`NCT03221985` - ESM Pilot: Mobile Phones and Psychology	N/A
Completed	`NCT02619474` - The Effect of Whiteboards on Patient Satisfaction	N/A
Completed	`NCT02267265` - Pilot Study of Novel Postpartum Educational Video Intervention	N/A
Completed	`NCT03203018` - Health Literacy and Cardiovascular Knowledge Workshop in Women From Disadvantaged Communities	N/A
Completed	`NCT02695316` - Barrier-free Communication in Maternity Care of Allophone Migrants	N/A
Completed	`NCT01933789` - Improving Communication About Serious Illness	N/A
Completed	`NCT01697137` - Patient and Physician Intervention to Increase Organ Donation	N/A
Completed	`NCT01459744` - An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations	N/A
Recruiting	`NCT01170000` - Timely End-of-Life Communication to Parents of Children With Brain Tumors	N/A
Completed	`NCT01040975` - Teen CHAT: Improving Physician Communication With Adolescents About Healthy Weight	N/A
Completed	`NCT03044145` - The Cultural Formulation Interview-Engagement Aid	N/A
Recruiting	`NCT04533126` - Channels of Communication & Brain Functioning: Pilot fMRI Study
Withdrawn	`NCT03901547` - Emotion Regulation and Burnout Impact on Communication Documentation	N/A
Completed	`NCT06081660` - Advance Care Planning for Older Latinos With Chronic Illness	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Multicenter Study to Evaluate a Systematized Communication Model for Breast Cancer Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms